Jordan P. Ball

Jordan P. Ball

Auto-generated profile, based on publicly available information

Jordan P. Ball

Department of Materials Science and Engineering, University of Florida, Rhines Hall, Gainesville, FL 32611, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2013 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
JBJordan P. Ball
Jordan P. Ball
BMBrittnee A. Mound
Brittnee A. Mound
JNJuan Claudio Nino
Juan Claudio Nino
JAJosephine Allen
Josephine Allen

21 February 2014 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
JBJordan P. Ball
Jordan P. Ball
BMBrittnee A. Mound
Brittnee A. Mound
AMAdam G. Monsalve
Adam G. Monsalve
JNJuan Claudio Nino
Juan Claudio Nino
JAJosephine Allen
Josephine Allen

23 June 2014 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
KBKevin Baler
Kevin Baler
JBJordan P. Ball
Jordan P. Ball
ZCZdravka Cankova
Zdravka Cankova
RHRyan A. Hoshi
Ryan A. Hoshi
GAGuillermo A. Ameer
Guillermo A. Ameer
JAJosephine Allen
Josephine Allen
The field of orthopedic tissue engineering is quickly expanding with the development of novel materials and strategies designed for rapid bone regeneration. While autologous bone grafts continue to be the standard of care, drawbacks include donor-site morbidity and short tissue supplies. Herein we report a novel nanocomposite sponge composed of poly(1,8-octanediol-co-citrate) (POC) and the bioactive ceramic β-tricalcium phosphate (TCP). We show that these nanocomposite sponges can be used as a depot for bone-producing (a.k.a. osteogenic) growth factors. In vitro bioactivity is demonstrated by significant upregulation of osteogenic genes, osteopontin (∼3 fold increase), osteocalcin (∼22 fold increase), alkaline phosphatase (∼10 fold increase), and transcription factor, RUNX2 (∼5 fold increase) over basal expression levels in mesenchymal stem cells. In vivo osteogenicity and biocompatibility is demonstrated in a standard subcutaneous implant model in rat. Results show that the nanocomposite sponge supports complete cell infiltration, minimal adverse foreign body response, positive cellular proliferation, and cellular expression of osteogenic markers in subcutaneous tissue. The results shown herein are encouraging and support the use of this sponge for future bone tissue engineering efforts.